scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.1780350409 |
P698 | PubMed publication ID | 1567490 |
P2093 | author name string | Bernstein RM | |
Black D | |||
Creed F | |||
Holt PJ | |||
Hay EM | |||
Huddy A | |||
Tomenson B | |||
P2860 | cites work | The study of the psychiatric symptoms of systemic lupus erythematosus. A biometric study. | Q52120537 |
Verbal fluency as a function of a measure of verbal intelligence and in relation to different types of cerebral pathology. | Q52276226 | ||
The Occurrence of Psychiatric Illness in Systemic Lupus Erythematosus | Q46438390 | ||
The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients | Q48369404 | ||
psychiatric symptoms in patients with systemic lupus erythematosus. | Q52102406 | ||
P433 | issue | 4 | |
P921 | main subject | cognitive dysfunction | Q57859955 |
systemic lupus erythematosus | Q1485 | ||
P304 | page(s) | 411-416 | |
P577 | publication date | 1992-04-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Psychiatric disorder and cognitive impairment in systemic lupus erythematosus | |
P478 | volume | 35 |
Q41647250 | A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus |
Q52031265 | Altered levels of neuropeptides characterize the brain of lupus prone mice. |
Q47825982 | An investigation in the possible effect of chronic headache on neuropsychological function in aCL-negative patients with SLE. |
Q34059923 | Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes |
Q71775354 | Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus |
Q48465933 | Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus |
Q24805595 | Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies |
Q48115169 | Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus |
Q48334054 | Brain synaptosomal antibodies in systemic lupus erythematosus |
Q37019825 | Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus |
Q48280000 | Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations |
Q40584328 | Changes in the clinical and laboratory features of lupus patients after the big earthquake in Taiwan |
Q88094564 | Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis |
Q40827014 | Cognitive changes in systemic lupus erythematosus |
Q35625220 | Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus |
Q55305136 | Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study. |
Q36434125 | Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment |
Q48961470 | Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity |
Q33567067 | Controversies in lupus: nervous system involvement |
Q38660157 | Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE) |
Q46152193 | DSM-III-R classification of psychiatric symptoms in systemic lupus erythematosus |
Q39930637 | Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study |
Q47915544 | Depression in systemic lupus erythematosus patients is associated with link-polymorphism but not methylation status of the 5HTT promoter region |
Q44289531 | Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study |
Q31933342 | Evaluation of patients with CNS involvement in SLE. |
Q38650121 | Gulf War illness (GWI) as a neuroimmune disease |
Q32064256 | Identification and cloning of a brain autoantigen in neuro-behavioral SLE. |
Q51986532 | Lateralized cognitive dysfunction in patients with systemic lupus erythematosus. |
Q44752066 | Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: a functional magnetic resonance imaging study. |
Q40416808 | Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus |
Q40929944 | Nervous system lupus: pathogenesis and rationale for therapy |
Q34213820 | Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage |
Q34075832 | Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience |
Q33566498 | Neuropsychological analysis in patients with systemic lupus erythematosus: a case control study |
Q33339985 | Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis |
Q36392300 | Neuropsychological patterns in systemic lupus erythematosus patients with depression |
Q51069301 | Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. |
Q47802635 | Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients |
Q34160129 | Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience |
Q36896792 | Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials |
Q57089661 | Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system |
Q51074622 | Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease. |
Q41032402 | Psychiatric disorder and cognitive impairment in SLE. |
Q37768381 | Quality-of-life measurements versus disease activity in systemic lupus erythematosus |
Q40519956 | Rehabilitation in joint and connective tissue diseases. 1. Systemic diseases |
Q40926905 | Research methods for investigating causal relations between SLE disease variables and psychiatric symptomatology. |
Q84078404 | SLE-related longitudinal myelitis with favorable outcome |
Q38459101 | Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE). |
Q34085879 | Stress and rheumatic diseases. |
Q50913353 | Stress as a predictor of cognitive functioning in lupus. |
Q48079385 | Symptoms of attention deficit hyperactivity disorder in patients with systemic lupus erythematosus. |
Q41025088 | Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study. |
Q46713726 | The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE. |
Q48220131 | The etiology of psychiatric symptoms in patients with systemic lupus erythematosus. |
Q33808136 | The psychiatric side effects of corticosteroids |
Q52002948 | Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition test. |
Q73200543 | [Autoimmunity: a concept to be revisited?] |
Q73209075 | [Psychoimmunology: a questionable model?] |
Search more.